INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 163 filers reported holding INSMED INC in Q1 2019. The put-call ratio across all filers is 0.84 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,753,000 | +3177.9% | 220,665 | +2894.1% | 0.28% | +2208.3% |
| Q2 2022 | $145,000 | +15.1% | 7,370 | +37.3% | 0.01% | +20.0% |
| Q1 2022 | $126,000 | -99.0% | 5,368 | -98.8% | 0.01% | -98.6% |
| Q4 2021 | $12,034,000 | -18.3% | 441,773 | -17.4% | 0.70% | -19.5% |
| Q3 2021 | $14,737,000 | -38.7% | 535,120 | -36.6% | 0.87% | -37.0% |
| Q2 2021 | $24,025,000 | +14.0% | 844,169 | +36.4% | 1.38% | +9.3% |
| Q1 2021 | $21,081,000 | +104.5% | 618,950 | +99.9% | 1.27% | +106.4% |
| Q4 2020 | $10,309,000 | -47.9% | 309,662 | -49.7% | 0.61% | -58.1% |
| Q3 2020 | $19,771,000 | +48.3% | 615,143 | +27.1% | 1.47% | +74.5% |
| Q2 2020 | $13,328,000 | +227.3% | 483,967 | +245.6% | 0.84% | +114.3% |
| Q1 2019 | $4,072,000 | – | 140,057 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |